ELM(Engineered Living Material) : 의료 분야 기회 - 시장 및 기술(2027-2047년)

Summary

Live to the age of 120 years? Have better organs grown for you? Treat currently incurable diseases? The unique 241-page report, “Engineered Living Material: Medical Opportunities: Markets, Technology 2027-2047” details these and allied commercial opportunities from Engineered Living Materials ELM. Some call them simply Living Materials. Grown-to-purpose, they are alive during use. This easily-understood guide is primarily for those wishing to manufacture, market and use ELM or their constituent added-value materials both living and inanimate.

There is also much to interest those wishing to invest in ELM, the legislators, commentators, researchers, product integrators and others in the emerging value chain. The report shuns history and technical obscurity to provide commercially-useful information to those that do not necessarily have a deep technical background in the key subjects such as biology or medicine but do have the science basics. It includes many identified challenges that are your opportunities. Your route to even further detail is the large numbers of 2025 and 2026 research papers cited and assessed and other new Zhar Research reports from the Zhar Research medical hardware series shown.

ELM virtuosity derisks investment

Dr Peter Harrop, primary author and Zhar Research CEO advises, “ELM can be the key to us living much longer and more healthily, with massive benefits to society. One part of that is growing organs that are more abundant and of better quality than transplants, but there is more – much more - that can be commercialised before that. One example is ELM drug delivery responsive to need in real time, as sensed by that ELM. From cancer to contact lenses and wound therapies, all detailed here, the sheer scope of ELM derisks your investment.

Unique clarity and expert insight

The emphasis is clarity and insight provided by PhD level analysis and forecasts presented as new infograms, Success Weakness Opportunity Threat SWOT appraisals, roadmaps, graphs, comparison tables and detailed bullet conclusions in simple language. Importantly, there is a very thorough look at the very latest research worldwide for 2025 and 2026 with constant updates, so you only get the latest. Old information can be very misleading in what is now a rapidly advancing subject with a surging pipeline of research and some useful new advances from the rather small number of companies involved – and profiled here - that are manufacturing ELM and their constituent parts. This analysis provides balanced judgement not evangelism. You are invited to get in at the beginning of this multi-billion-dollar addressable market, not least by addressing the impediments identified in this report, your essential, commercially-oriented guidebook into the subject.

The chapters

The Executive Summary and Conclusions (37 pages) is sufficient for those in a hurry, for here are the basics, mainly as infograms, the 18 forecast lines 2027-2047 as tables and graphs with explanation and the 19 key conclusions split into market and then technical/ company aspects with analysis pie charts including relative popularity of scaffold/ matrix materials and the living materials they support, manufacturers by territory and so on – facts-based research.

The rest of the report is strongly powered by a close look at the flood of ELM research that arrived in 2026 and 2025 adding new benchmarking and manufacturer analysis. The Introduction (47 pages) gives the ELM definition, introduces simple subsets, objectives and applications 2027-2047 and its place in science, healthcare and particularly regenerative medicine. See how ELM are trending strongly. It then puts ELM in context by benchmarking the longevity and self-healing abilities found in nature. Then come examples of biomimetic ELM and allied research progress including researchers copying the octopus to make soft robotics self-healing for surgery and prosthetics. The chapter ends with a close look at the strong pursuit of self-healing materials: putting ELM in this context with infograms and SWOT appraisal.

Chapter 3. Engineered Living Materials ELM Basics (39 pages) gives the detail on this with, examples of progress towards ELM, features created, ELM design approaches including bio-ELM vs hybrid HLM, architecture and materials, the living carrier matrix, eukaryotic vs prokaryotic, stages of creation and deployment. Learn why hydrogels are popular for ELM scaffolds and fungal ELM is important. Bio-imaging, cell-sensing, other photon manipulation are covered then obstacles and the way forward.

Chapter 4. Commercial Opportunities Arising from ELM Research Advances 2025-6 is a full 63 pages going into deep detail on your opportunities by type of therapy (13 important examples detailed). Then comes the large amount of new ELM advances 2024 through 2026 that are not specific to one therapy. Pie charts, SWOT, detailed tables and text clarify. 210 research papers are covered.

Chapter 5. Manufacturing Technology for ELM Structures (20 pages) goes beyond the synthesis of ELM as composite feedstock that has been covered earlier to the next stage of creating useful structures. That includes lithography, but with additive manufacture such as electrospinning being preferred (reasons given). See why 3D and 4D printed ELM are particularly favoured and understand including the bio-ink preparation and the alternatives such as growing bacteria into centimeter-scale structures.

Chapter 6. Medical ELM Manufacturers Emerging (22 pages) gives context and analysis and profiles organisations spinning off ELM companies. It then profiles ten leading ELM companies, showing that there is scope for far more.

Zhar Research report, “Engineered Living Material: Medical Opportunities: Markets, Technology 2027-2047” is your best guide. It is the only comprehensive, up-to-date report giving your opportunities with ELM, with extensive new insights, data and predictions not available from old reports or AI alone. It is written by someone with a track record of creating successful new companies.

CAPTION: Material from the Zhar Research report, “Engineered Living Material: Medical Opportunities: Markets, Technology 2027-2047” – cover, methodology and graphic of the self-healing aspect.

Table of Contents

1. Executive summary and conclusions

• 1.1 Purpose of this report
• 1.2 Methodology of this analysis
• 1.3 Engineering Living Materials definition, simple subsets, SWOT appraisals
• 1.4 Biomimetic ELM design approaches
• 1.5 Four stages of ELM creation and deployment
• 1.6 Features designed into engineered living materials
• 1.7 Engineered Living Material objectives and applications 2027-2047
• 1.8 ELM place in science and healthcare
• 1.9 Primary conclusions: emerging ELM markets with new infograms and pie chart analysis
• 1.10 Primary conclusions: ELM design, materials, manufacturing with new infograms, SWOT and pie chart analysis
• 1.11 Roadmap for healthcare ELM 2027-2047
• 1.12 Market forecasts in 18 lines 2027-2047 with explanation and commentary
  • 1.12.1 Market structure and uncertainties
  • 1.12.2 Healthcare ELM grown organ implants vs other $ billion cautious forecast 2027-2047
  • 1.12.3 Healthcare ELM grown organ implants vs other $ billion topside forecast 2027-2047
  • 1.12.4 Self-healing materials market for all applications: ELM vs total 2027-2047
  • 1.12.5 Self-healing materials for healthcare value market: patient vs buildings and equipment $ billion 2027-2047
  • 1.12.6 Percentage share of healthcare ELM value market by four regions 2027-2047
  • 1.12.7 Number of healthcare ELM manufacturers 2027-2047

2. Definitions, inspiration from nature, regenerative medicine, progress towards ELM

• 2.1 Engineering Living Materials definition and simple subsets
• 2.2 ELM objectives and applications 2027-2047
• 2.3 ELM place in science and healthcare
• 2.4 How ELM are trending strongly
• 2.5 Inspiration from nature: longevity and self-healing
  • 2.5.1 Design principles of living materials
  • 2.5.2 Sea grass, giant tortoise, salamander, sea cucumber, jellyfish, starfish, hydra, zebra fish, sea spiders, spiny mouse
  • 2.5.3 ELM at the interface of living and inanimate
• 2.6 Some examples of biomimetic ELM and allied research progress
  • 2.6.1 Researchers copy the octopus to make soft robotics self-healing for surgery, prosthetics
  • 2.6.2 Strong pursuit of self-healing materials: ELM in context
• 2.7 Current regenerative medicine and ambitions for the future
  • 2.7.1 Definition and focus
  • 2.7.2 Regenerative medicine in
  • 2.7.3 Regenerative medicine and Engineered Living Materials

3. Engineered Living Materials ELM basics

• 3.1 Overview: ELM design approaches
• 3.2 Examples of progress towards ELM
• 3.3 Bio ELM vs hybrid HLM
  • 3.3.1 Architecture and materials
  • 3.3.2 Later stage: the living carrier matrix
• 3.4 Eukaryotic vs prokaryotic ELM
• 3.5 Some features designed into engineered living materials
• 3.6 Four stages of ELM creation and deployment
• 3.7 Why hydrogels are popular for ELM scaffolds
• 3.8 Importance of fungal ELM
• 3.9 Bio-imaging, cell-sensing, other photon manipulation
• 3.10 Obstacles and the way forward

4. Commercial opportunities arising from ELM research advances 2025-6

• 4.1 Lessons from ELM research and industrial initiatives
• 4.2 SWOT appraisal of biomedical Engineered Living Materials ELM
• 4.3 Early examples of ELM research compared
• 4.4 Biomedical ELM research advances 2025-6 by targetted therapy
  • 4.4.1 Articular cartilage (AC) repair
  • 4.4.2 Bioremediation and biotherapeutics ELM
  • 4.4.3 Bioelectrical nerve stimulation, physiological blood pressure signals by living hydrogels
  • 4.4.4 Cancer immunotherapy
  • 4.4.5 Contact lenses that are living and self-lubricating
  • 4.4.6 Drug delivery responding to sensed need in real time
  • 4.4.7 Immune engineering
  • 4.4.8 Infectious keratitis therapy
  • 4.4.9 Inflammatory bowel disease
  • 4.4.10 Micro/Nano-Robots: targeted therapy, minimally invasive intervention, medical imaging
  • 4.4.11 Skin disorders
  • 4.4.12 Vaginal imbalances and other conditions
  • 4.4.13 Wound healing: biobandages, Engineered Blood Clots EBC, dental
• 4.5 Biomedical ELM research advances 2024 through 2026 not specific to one therapy
  • 4.5.1 Expanding the ELM functional toolbox
  • 4.5.2 AI design creates new ELM options
  • 4.5.3 Bacterial species in ELM
  • 4.5.4 Biomimetic localized assembly enhances biomedical ELM
  • 4.5.5 Bioengineered living materials
  • 4.5.6 Constrained cell growth unravelled
  • 4.5.7 Multistrain collaboration ELM
  • 4.5.8 Living carrier matrices enable self-growing and mechanically tunable ELM
  • 4.5.9 Tuning ELM polymer matrices to direct microbial adhesion, growth, spatial organization, and phenotype
  • 4.5.10 Programmable materials grown directly from living cells as ELM
  • 4.5.11 Synthetic biology for ELM
• 4.6 71 Research advances 2024-6 somewhat relevant to biomedical ELM

5. Manufacturing technology for ELM structures

• 5.1 Overview: synthesis, lithography, additive manufacture such as electrospinning, other options
• 5.2 3D and 4D printed ELM including the bioink preparation
• 5.3 Growing bacteria into centimeter-scale structures
• 5.4 Other options

6. Medical ELM manufacturers emerging

• 6.1 Overview
  • 6.1.1 The Advanced Regenerative Manufacturing Institute (ARMI) USA
  • 6.1.2 European Innovation Council (EIC) Europe
  • 6.1.3 Wyss Institute at Harvard University USA
• 6.2 Companies making ELM and closely allied products
  • 6.2.1 Bluepha China
  • 6.2.2 Ecovative Design USA
  • 6.2.3 Evonik Industries Germany
  • 6.2.4 Ginkgo Bioworks USA
  • 6.2.5 GsynBioT China
• 6.3 Companies with somewhat relevant technology to ELM
  • 6.3.1 AMSilk Germany
  • 6.3.2 Aquestive Therapeutics USA
  • 6.3.3 Arsenal Medical USA
  • 6.3.4 Biomason USA
  • 6.3.5 Caravan Biologix USA
  • 6.3.6 MDimune South Korea
  • 6.3.7 Modern Synthesis UK
  • 6.3.8 Mycoworks (DFX Corporation) USA
  • 6.3.9 PhaBuilder China
  • 6.3.10 Zhejiang Chuanhua Yixin New Materials Co., Ltd China.